After Bharat Biotech, Zydus COVID-19 vaccine candidate gets nod from Centre for human trials
The potential vaccine showed a "strong immune response" in animal studies, and the antibodies produced were able to completely neutralize the wild type virus, Zydus, part of Cadila Healthcare Ltd, said in a statement to Indian stock exchanges.
Zydus has received approval from regulators to begin human studies for its COVID-19 vaccine contender, the drugmaker said on Friday, Photo: Reuters